An update on recent cutting-edge trials: Treatments now available for newly diagnosed mHSPC patients
Dr. Neal Shore, Assoc. Prof. Neeraj Agarwal and Prof. Steven Joniau provide their thoughts and views on treatments for newly diagnosed mHSPC (Metastatic Hormone Sensitive Prostate Cancer) patients following recent cutting-edge trials.
Introduction: Dr. Neal Shore
US Perspective: Assoc. Prof. Neeraj Agarwal
EU Perspective: Prof. Steven Joniau
Conclusion: Dr. Neal Shore